跳至主要内容
临床试验/NL-OMON49528
NL-OMON49528招募中不适用

Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic acid) in pleural empyema fluid and complicated parapneumonic effusion - Empyema-study

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years
  • Diagnosed with pleural empyema or complicated parapneumonic effusion, based on
  • the criteria mentioned below, and in need of pleural fluid drainage.
  • o presence of pus or positive Gram*s stain or culture from the pleural fluid.
  • o pleural pH<7.2 or pleural fluid glucose value <2.2 mmol/l or pleural fluid
  • LDH value >1000 IU/L
  • Receiving IV amoxicillin 1000mg 4 times daily or amoxicillin-clavulanic acid
  • 1000/200mg 4 times daily; dosage if necessary adapted to renal function
  • Able and willing to give informed consent (or consent by family member or legal
  • representative)

排除标准

  • Critically ill patients admitted to the ICU, or patients of the general ward
  • who became critically ill and got transferred to the ICU during the duration of
  • Pre-existing ipsilateral pleural effusion or other cause of pleural effusion
  • (e.g. cancer) more likely.

研究者

相似试验